Stimulant ADHD medication and risk for substance abuse

Cited by (222)

Items 201–222 of 222

1. Answering Parent Questions About Attention-Deficit/Hyperactivity Disorder
   Rachel Ballard, Alba Pergjika · 2025 · Pediatric Annals
2. Special Cases
   Anupriya Gogne · 2025 · Springer eBooks
3. A Perturbação por Uso de Substâncias como Comorbilidade em Doentes com Perturbação de Hiperatividade e Défice de Atenção
   Maria Inês Ribeiro, Gustavo França · 2025 · Acta Médica Portuguesa
4. The diagnosis and pharmacotherapy of Adult ADHD - part 1
   Michal Vodička · 2025 · Psychiatrie pro praxi
5. ADHD brains present unique challenges, but the condition is highly treatable − a primary care nurse practitioner with ADHD explains the science
   Kate Harrington · 2024
6. An examination of the impact of treatment on later risk for a substance use disorder in young people with major depressive disorder and bipolar disorder
   Amy M. Yule, A. Kim, Katy Burns, Maura DiSalvo, Vinod Rao, Mira Stone, Sylvia R. Lanni, Timothy E. Wilens · 2025 · Journal of Mood and Anxiety Disorders
7. ADHD , substance use disorders and stimulant treatment: understanding the relationships
   Jeffrey H. Newcorn · 2025 · World Psychiatry
8. ADHD – A GLOBAL CHALLENGE. ARE WE CLOSER TO THE IDEAL THERAPY?
   Karina Grzesik, Katarzyna Pilarczyk, Aleksandra Rabęda, Antoni Gawor, Natalia Klepacz · 2025 · International Journal of Innovative Technologies in Social Science
9. Attention Deficit Hyperactivity Disorder
   Albert Lee Muh Haur, Leslie Chai Jia Le · 2025 · Springer eBooks
10. The diagnosis and pharmacotherapy of adult ADHD - part 2
    Michal Vodička · 2025 · Psychiatrie pro praxi
11. Medication Adherence in Children and Adults Receiving Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Sweden: A Nationwide Study
    MaiBritt Giacobini, Jianlin Zhao, Jonatan Freilich, Carolina Brünner, Niklas Wallin Bernhardsson, Ewa Ahnemark · 2026 · Journal of Attention Disorders
12. Reduced risk of cause-specific hospitalisations and all-cause hospitalisation/mortality during treatment with attention-deficit/hyperactivity disorder medications in the course of bipolar disorder: a Swedish registry-based within-subject cohort study
    Çağatay Ermiş, Antti J. Tanskanen, Olivier Corbeil, Johannes Lieslehto, Eduard Vieta, Christoph Ulrich Correll, Ellenor Mittendorfer-Rutz, Jari Tiihonen, Heidi T. Taipale · 2026 · BMJ Mental Health
13. Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational study
    Patrick Bach, Johan Franck, Jonas Hällgren · 2026 · The Lancet Regional Health - Europe
14. Diagnosis and Management of Adult Attention-Deficit/Hyperactivity Disorder
    Emma Worringer, Michael Caçoilo · 2026 · Primary Care Clinics in Office Practice
15. Attention-Deficit/Hyperactivity Disorder, Racial Disparities, and Involvement in the Juvenile Justice System: A Narrative Review
    Justin B Atkins, Oscar A Toro Ruilowa, Deanna Chea, Caitlin Chen · 2026 · Cureus
16. Komorbiditäten
    Christian Lorenz · 2026 · Springer eBooks
17. Treat comorbid attention-deficit hyperactivity disorder and substance use disorder with both pharmacotherapy and psychotherapy for best results
    Kimberley Chen, Connie Kang · 2026 · Drugs & Therapy Perspectives
18. Systematic Review and Meta-Analysis of Attention Deficit Hyperactivity Disorder: First Estimates of the Prevalence by Sex Amongst People Who Use Psychoactive Substances and Alcohol
    Catherine Maria Comiskey, David McDonagh, Prakashini Banka, Philip David James, Sadie Lavelle-Cafferkey, Jessica Eustace‐Cook · 2026 · Journal of Dual Diagnosis
19. ADHD medication and the risk for substance use disorder, where do they meet?
    Tibor M. Brunt, Cleo Lina Crunelle, Wim van den Brink · 2026 · Addiction Research & Theory
20. Addictive Potential of Methylphenidate: A Systematic Review of Human and Preclinical Behavioral, Clinical and Neurobiological Evidence
    Rafał Bieś, Adam Chabrzyk, Katarzyna Zborowska, Krzysztof Krysta, Marek Krzystanek · 2026 · Pharmaceuticals
21. Prevalence of stimulant use among adolescents and young adults by pseudo-cohort and sex: evidence from a national survey
    Lauren Klein Warren, Chris Delcher, Noah I Smith, Joëlla W. Adams, Georgiy Bobashev · 2026 · The American Journal of Drug and Alcohol Abuse
22. BEYOND SYMPTOM CONTROL: ADHD PHARMACOTHERAPY AND REAL-WORLD RISK REDUCTION – A NARRATIVE REVIEW
    Lena Gluszkiewicz, Sara Elżbieta Czubak, Michalina Weronika Nieścioruk, Dominika Julia Kozdroń, Jan Szafranek, Julia Beata Woźniak, Jakub Marcel Korowicki · 2026 · International Journal of Innovative Technologies in Social Science